Members-only Site   |   Print Page   |   Contact Us   |   Sign In   |   Register
News & Press: Breaking News

P&T Community March Edition: Confusion From the FDA on Compounding

Tuesday, March 8, 2016   (0 Comments)
Posted by: Dagmar Anderson
Share |

IACP is quoted in March's P&T Community edition, "Confusion From the FDA on Compounding: Agency Tries to Expand List of Useable “Bulk Drug Substances."


"Pharmacy groups are highly critical of the FDA’s moves, mostly for reasons of process. 'Congress made it very clear that FDA must take all bulk drug nominations through its Pharmacy Compounding Advisory Committee (PCAC),' says Dagmar Anderson, Vice President of Communications at the International Academy of Compounding Pharmacists. “This appears to be an additional attempt by the FDA to circumvent congressional intent.”


Click here to read the entire article.

Association Management Software Powered by YourMembership  ::  Legal